vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Ollie's Bargain Outlet Holdings, Inc. (OLLI). Click either name above to swap in a different company.

Ollie's Bargain Outlet Holdings, Inc. is the larger business by last-quarter revenue ($613.6M vs $487.7M, roughly 1.3× CLOVER HEALTH INVESTMENTS, CORP.). Ollie's Bargain Outlet Holdings, Inc. runs the higher net margin — 7.5% vs -10.1%, a 17.6% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 18.6%). Ollie's Bargain Outlet Holdings, Inc. produced more free cash flow last quarter ($-26.0M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs -2.8%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Ollie's Bargain Outlet is an American discount store chain. It was founded in Mechanicsburg, Pennsylvania, in 1982 by Morton Bernstein, Mark Butler, Harry Coverman, and Oliver "Ollie" Rosenberg, the company's namesake. As of September 2025, the chain has 618 locations in 34 states. Its selection of merchandise comprises a variety of discounted items, mostly overstock or closeout merchandise that is purchased in bulk from other retailers and sold at discounted prices. Ollie's Bargain Outlet st...

CLOV vs OLLI — Head-to-Head

Bigger by revenue
OLLI
OLLI
1.3× larger
OLLI
$613.6M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+26.1% gap
CLOV
44.7%
18.6%
OLLI
Higher net margin
OLLI
OLLI
17.6% more per $
OLLI
7.5%
-10.1%
CLOV
More free cash flow
OLLI
OLLI
$43.0M more FCF
OLLI
$-26.0M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
-2.8%
OLLI

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
CLOV
CLOV
OLLI
OLLI
Revenue
$487.7M
$613.6M
Net Profit
$-49.3M
$46.2M
Gross Margin
41.3%
Operating Margin
-10.1%
9.0%
Net Margin
-10.1%
7.5%
Revenue YoY
44.7%
18.6%
Net Profit YoY
-123.2%
28.7%
EPS (diluted)
$0.75

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
OLLI
OLLI
Q4 25
$487.7M
$613.6M
Q3 25
$496.6M
$679.6M
Q2 25
$477.6M
$576.8M
Q1 25
$462.3M
$667.1M
Q4 24
$337.0M
$517.4M
Q3 24
$331.0M
$578.4M
Q2 24
$356.3M
$508.8M
Q1 24
$346.9M
$648.9M
Net Profit
CLOV
CLOV
OLLI
OLLI
Q4 25
$-49.3M
$46.2M
Q3 25
$-24.4M
$61.3M
Q2 25
$-10.6M
$47.6M
Q1 25
$-1.3M
$68.6M
Q4 24
$-22.1M
$35.9M
Q3 24
$-9.2M
$49.0M
Q2 24
$7.4M
$46.3M
Q1 24
$-19.2M
$76.5M
Gross Margin
CLOV
CLOV
OLLI
OLLI
Q4 25
41.3%
Q3 25
39.9%
Q2 25
41.1%
Q1 25
40.7%
Q4 24
41.4%
Q3 24
24.5%
37.9%
Q2 24
30.3%
41.1%
Q1 24
23.6%
40.5%
Operating Margin
CLOV
CLOV
OLLI
OLLI
Q4 25
-10.1%
9.0%
Q3 25
-4.9%
11.3%
Q2 25
-2.2%
9.7%
Q1 25
-0.3%
13.2%
Q4 24
-6.4%
8.6%
Q3 24
-2.7%
10.5%
Q2 24
2.0%
11.1%
Q1 24
-6.5%
15.0%
Net Margin
CLOV
CLOV
OLLI
OLLI
Q4 25
-10.1%
7.5%
Q3 25
-4.9%
9.0%
Q2 25
-2.2%
8.2%
Q1 25
-0.3%
10.3%
Q4 24
-6.6%
6.9%
Q3 24
-2.8%
8.5%
Q2 24
2.1%
9.1%
Q1 24
-5.5%
11.8%
EPS (diluted)
CLOV
CLOV
OLLI
OLLI
Q4 25
$0.75
Q3 25
$0.99
Q2 25
$0.77
Q1 25
$1.11
Q4 24
$0.58
Q3 24
$0.79
Q2 24
$0.75
Q1 24
$1.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
OLLI
OLLI
Cash + ST InvestmentsLiquidity on hand
$78.3M
$144.7M
Total DebtLower is stronger
$1.1M
Stockholders' EquityBook value
$308.7M
$1.8B
Total Assets
$541.0M
$2.9B
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
OLLI
OLLI
Q4 25
$78.3M
$144.7M
Q3 25
$231.2M
Q2 25
$199.0M
Q1 25
$205.1M
Q4 24
$194.5M
$128.7M
Q3 24
$288.0M
$170.6M
Q2 24
$254.8M
$212.3M
Q1 24
$208.3M
$266.3M
Total Debt
CLOV
CLOV
OLLI
OLLI
Q4 25
$1.1M
Q3 25
$912.0K
Q2 25
$925.0K
Q1 25
$1.0M
Q4 24
$1.0M
Q3 24
$984.0K
Q2 24
$1.1M
Q1 24
$1.0M
Stockholders' Equity
CLOV
CLOV
OLLI
OLLI
Q4 25
$308.7M
$1.8B
Q3 25
$340.9M
$1.8B
Q2 25
$344.2M
$1.7B
Q1 25
$336.1M
$1.7B
Q4 24
$341.1M
$1.6B
Q3 24
$342.2M
$1.6B
Q2 24
$324.9M
$1.5B
Q1 24
$292.5M
$1.5B
Total Assets
CLOV
CLOV
OLLI
OLLI
Q4 25
$541.0M
$2.9B
Q3 25
$559.7M
$2.8B
Q2 25
$575.0M
$2.7B
Q1 25
$583.7M
$2.6B
Q4 24
$580.7M
$2.5B
Q3 24
$653.0M
$2.4B
Q2 24
$674.2M
$2.3B
Q1 24
$671.8M
$2.3B
Debt / Equity
CLOV
CLOV
OLLI
OLLI
Q4 25
0.00×
Q3 25
0.00×
Q2 25
0.00×
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
OLLI
OLLI
Operating Cash FlowLast quarter
$-66.9M
$4.8M
Free Cash FlowOCF − Capex
$-69.0M
$-26.0M
FCF MarginFCF / Revenue
-14.1%
-4.2%
Capex IntensityCapex / Revenue
0.4%
5.0%
Cash ConversionOCF / Net Profit
0.10×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$153.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
OLLI
OLLI
Q4 25
$-66.9M
$4.8M
Q3 25
$12.1M
$80.7M
Q2 25
$5.4M
$28.7M
Q1 25
$-16.3M
$147.8M
Q4 24
$34.8M
$-4.4M
Q3 24
$50.0M
$43.9M
Q2 24
$44.8M
$40.2M
Q1 24
$25.9M
$143.6M
Free Cash Flow
CLOV
CLOV
OLLI
OLLI
Q4 25
$-69.0M
$-26.0M
Q3 25
$11.4M
$54.3M
Q2 25
$4.8M
$2.0M
Q1 25
$-16.5M
$123.4M
Q4 24
$33.3M
$-35.4M
Q3 24
$49.6M
$5.6M
Q2 24
$44.4M
$13.3M
Q1 24
$25.5M
$100.6M
FCF Margin
CLOV
CLOV
OLLI
OLLI
Q4 25
-14.1%
-4.2%
Q3 25
2.3%
8.0%
Q2 25
1.0%
0.3%
Q1 25
-3.6%
18.5%
Q4 24
9.9%
-6.8%
Q3 24
15.0%
1.0%
Q2 24
12.5%
2.6%
Q1 24
7.3%
15.5%
Capex Intensity
CLOV
CLOV
OLLI
OLLI
Q4 25
0.4%
5.0%
Q3 25
0.1%
3.9%
Q2 25
0.1%
4.6%
Q1 25
0.0%
3.7%
Q4 24
0.5%
6.0%
Q3 24
0.1%
6.6%
Q2 24
0.1%
5.3%
Q1 24
0.1%
6.6%
Cash Conversion
CLOV
CLOV
OLLI
OLLI
Q4 25
0.10×
Q3 25
1.32×
Q2 25
0.60×
Q1 25
2.16×
Q4 24
-0.12×
Q3 24
0.90×
Q2 24
6.04×
0.87×
Q1 24
1.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons